Henan Lingrui Pharmaceutical Co (SHSE:600285) Other Net Income (Loss) : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Other Net Income (Loss)?

Henan Lingrui Pharmaceutical Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Henan Lingrui Pharmaceutical Co's quarterly Other Net Income (Loss) declined from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥0 Mil) but then increased from Dec. 2023 (¥0 Mil) to Mar. 2024 (¥0 Mil).

Henan Lingrui Pharmaceutical Co's annual Other Net Income (Loss) declined from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) and declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥-0 Mil).

Henan Lingrui Pharmaceutical Co Other Net Income (Loss) Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Other Net Income (Loss) Chart

Henan Lingrui Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Henan Lingrui Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Henan Lingrui Pharmaceutical Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Henan Lingrui Pharmaceutical Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550

Website

http://www.lingrui.com

Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Executives

Wu Xi Zhen	Director
Li Jin	Supervisors
Ye Qiang	senior management
Chen Yan	Directors, senior managers
Wu Hui Bin	senior management
Yu Peng	Director
Zhao Zhi Jun	Director
Li Lei	senior management
Feng Guo Xin	Directors, senior managers
Pan Zi Run	Director
Xiong Wei Zheng	Director
Tang Wei	Supervisors
Cheng Jian Jun	Director
Zhang Jun Bing	Director
Xia Hui	senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines